Novel Lipids of the Rabbit Harderian Gland Improve Tear Stability in an Animal Model of Dry Eye Disease.
Sep 28 2021
PubMed ID: 34590914 Author(s): Butovich IA, Yuksel S, Leonard B, Gadek T, Polans AS, Albert DM. Novel Lipids of the Rabbit Harderian Gland Improve Tear Stability in an Animal Model of Dry Eye Disease. J…
Read MorePilot Study of a “Large-Eye,” Surgically Induced Dry Eye Rabbit Model by Selective Removal of the Harderian, Lacrimal, and Meibomian Glands.
Dec 01 2017
PubMed ID: 29344500 Author(s): Polans AS, McAnulty JF, Phelps PO, Darjatmoko SR, Burris CK, Albert DM. Pilot study of a “large-eye,” surgically induced dry eye rabbit model by selective removal of the harderian, lacrimal, and…
Read MoreResveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
May 01 2017
PubMed ID: 27419830 Author(s): Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells…
Read MoreNatural products induce a G protein-mediated calcium pathway activating p53 in cancer cells.
Nov 01 2015
PubMed ID: 26341291 Author(s): van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD. Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells. Toxicol Appl Pharmacol. 2015 Nov 1;288(3):453-62. doi:…
Read MoreThe sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.
Oct 30 2014
PubMed ID: 25361423 Author(s): Kanavi MR, Darjatmoko S, Wang S, Azari AA, Farnoodian M, Kenealey JD, van Ginkel PR, Albert DM, Sheibani N, Polans AS. The sustained delivery of resveratrol or a defined grape powder…
Read MoreIntroducing Krzysztof Palczewski, the 2014 recipient of the Friedenwald award.
Oct 22 2014
PubMed ID: 25338685 Author(s): Polans AS. Introducing Krzysztof Palczewski, the 2014 recipient of the Friedenwald award. Invest Ophthalmol Vis Sci. 2014 Oct 22;55(10):6649-50. doi: 10.1167/iovs.14-14843. PMID 25338685 Journal: Investigative Ophthalmology & Visual Science, Volume 55,…
Read MoreA synergetic screening approach with companion effector for combination therapy: application to retinoblastoma.
Jan 01 2013
PubMed ID: 23527118 Author(s): Mahida JP, Antczak C, Decarlo D, Champ KG, Francis JH, Marr B, Polans AS, Albert DM, Abramson DH, Djaballah H. A synergetic screening approach with companion effector for combination therapy: application…
Read MoreAnti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.
Nov 01 2011
PubMed ID: 21854876 Author(s): Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. Anti-tumor and immunomodulatory activity of resveratrol in vitro and…
Read MoreResveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB.
Jun 01 2011
PubMed ID: 21407133 Author(s): Bhattacharya S, Darjatmoko SR, Polans AS. Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res. 2011 Jun;21(3):180-7.…
Read More